EFFECT OF TREATMENT WITH 4,5-DIHYDROXY2-CYCLOPENTEN-1-ONE (DHCP) ON GENE EXPRESSION AND QUORUMSENSING IN BACTERIA

Details for Australian Patent Application No. 2003218013 (hide)

Owner TAKARA BIO, INC.

Inventors PHADTARE, Sangita; KATO, Ikunoshin; INOUYE, Masayori

Pub. Number AU-A-2003218013

PCT Number PCT/US03/07081

PCT Pub. Number WO2003/077844

Priority 60/363,548 13.03.02 US; 60/402,041 09.08.02 US

Filing date 7 March 2003

Wipo publication date 29 September 2003

Event Publications

31 July 2003 Complete Application Filed

  Priority application(s): 60/363,548 13.03.02 US; 60/402,041 09.08.02 US

6 November 2003 Application Open to Public Inspection

  Published as AU-A-2003218013

2 December 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003218014-CANCER-LINKED GENE AS TARGET FOR CHEMOTHERAPY

2003218012-COMPACT APPARATUS FOR NONINVASIVE MEASUREMENT OF GLUCOSE THROUGH NEAR-INFRARED SPECTROSCOPY